PBE
Invesco Dynamic Biotechnology & Genome ETF
Save
About
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U. S. biotechnology and genome companies.
Biggest holdings
Health care
5.34%
Health care
5.31%
Health care
5.07%
Health care
5.06%
Health care
5.01%
Health care
4.95%
Health care
4.74%
Health care
4.72%
Health care
3.38%
Health care
3.24%
Similar securities
Based on sector and market capitalization
Report issue